Article Text

Download PDFPDF

O21.6 A Tale of Two Cities: Treponema Pallidum Macrolide Resistance in Colombo (Sri Lanka) and London (United Kingdom)
  1. D Mallikarachchi1,
  2. L Hodson2,
  3. C Duckett2,
  4. G Weerasinghe1,
  5. K Buddhakorale1,
  6. M McClure3,
  7. G Taylor3,
  8. C Tipple3
  1. 1National Centre for STD/AIDS Control, Colombo, Sri Lanka
  2. 2Imperial College Healthcare NHS Trust, London, UK
  3. 3Imperial College London, London, UK


Background The bacterium Treponema pallidum ( T. pallidum) causes syphilis. Penicillin is effective treatment, but azithromycin (a macrolide) is a single-dose oral alternative for those with allergy. Unfortunately, macrolide resistance secondary to one of two 23S ribosomal RNA (rRNA) point mutations (A2058G and A2059G) is now wide-spread. Molecular strain-typing suggests that epidemics and macrolide resistance are unlikely the spread of single clones.

We present typing and macrolide resistance data from two geographically distinct populations: Colombo, Sri Lanka and London, UK.

Methods Cross-sectional studies were conducted at the Colombo District STD clinics and St Mary’s Hospital, London. Ulcer exudate and/or blood were collected from patients with microbiologically confirmed syphilis. Presence of T. pallidum DNA ( tpp047 gene) was confirmed with PCR. Next, using published techniques, the 23SrRNAgene was PCR-amplified for a point-mutation assay and tpp0548, arp and tprE,G& Jamplicons were used for strain-typing.

Results Sri Lanka: 24 T. pallidum PCR-positive samples were collected. Patients were men (45.9% MSM) and 91.6% Sinhalese with a mean age of 28 (range 29). None were HIV-1 infected. Two strain types were discovered (14b/f and 13b/f), neither harbouring macrolide resistance.

London: 43 men were recruited, 18 in 2006–8 and 25 in 2011–12. Mean age was 37.5 (range 43); 95.2% were MSM and 62.8% were HIV-1 infected. Half (22/43) were white British. A total of 5 full and 14 partial strain types were identified, of which 6 were unique. Macrolide resistance increased from 66.7%(12/18) in 2006–8 to 80%(20/25) in 2011–12.

Conclusion Colombo T. pallidumstrains have limited diversity with no macrolide resistance. London strains are more varied and increasingly macrolide-resistant. Ethnic diversity in London exceeds Colombo’s and may explain increased strain diversity. In contrast to Sri Lanka, azithromycin is widely used to treat Chlamydia and non-specific urethritis in the UK thus selection pressure may be driving macrolide resistance.

  • antibiotic resistance
  • Sri Lanka
  • Syphilis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.